Lataa...
Who should be offered HIV pre-exposure prophylaxis (PrEP)?: A secondary analysis of a Phase 3 PrEP efficacy trial in men who have sex with men and transgender women
BACKGROUND: Pre-exposure prophylaxis (PrEP) has been proven to reduce HIV acquisition in men who have sex with men and transgender women (MSM/TGW). For maximal impact, PrEP should be targeted to subpopulations accounting for the largest proportion of infections (population attributable fraction, PAF...
Tallennettuna:
Päätekijät: | , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
2014
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133171/ https://ncbi.nlm.nih.gov/pubmed/24613084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(14)70025-8 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|